Literature DB >> 12003351

Pteridine derivatives as modulators of oxidative stress.

K Oettl1, G Reibnegger.   

Abstract

Pteridine derivatives which have a widespread occurrence in nature have been investigated upon their interactions with free radicals and free radical mediated reactions utilizing a number of different experimental systems. Searching for biological functions, which are still unknown for the majority of pteridine compounds, the effect of pteridines in systems like luminol-induced chemiluminescence, enzyme activity, DNA photodamage, EPR experiments or radical induced injury--just to name a few--have been investigated. The general view during the initial phase of investigations on this special field was, that reduced pterins, i. e., tetra- as well as dihydropterins, generally act as radical scavengers, while aromatic pterins, if not inactive, exert radical promoting activity. Meanwhile the data available provide a more complex view: pteridines of all oxidation states have been shown to act anti- or prooxidatively, depending on the special conditions of the experiment. The reason is that reduced pterins, besides of being scavengers of free radicals, also are strongly reducing agents and therefore, in the presence of transition metal ions promote Fenton chemistry. Aromatic pterins have been described as inhibitors or substrates of enzymes involved--in vitro and in vivo--in free radical generation. Together with the unknown local concentrations of, e.g., neopterin and dihydroneopterin occurring in vivo, these reasons make it impossible to unequivocally predict a physiological net effect of pterins of different oxidation states concerning free radical mediated reactions in real biological systems.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003351     DOI: 10.2174/1389200024605127

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  7 in total

1.  Ageing and the cost of maintaining coloration in the Australian painted dragon.

Authors:  Mathieu Giraudeau; Christopher R Friesen; Joanna Sudyka; Nicky Rollings; Camilla M Whittington; Mark R Wilson; Mats Olsson
Journal:  Biol Lett       Date:  2016-07       Impact factor: 3.703

2.  Influence of neopterin and 7,8-dihydroneopterin on the replication of Coxsackie type B5 and influenza A viruses.

Authors:  Olga Bratslavska; Diana Platace; Edvīns Miklasevics; Dietmar Fuchs; Agris Martinsons
Journal:  Med Microbiol Immunol       Date:  2006-07-26       Impact factor: 3.402

3.  The Nephroprotective Effects of α-Bisabolol in Cisplatin-Induced Acute Kidney Injury in Mice.

Authors:  Nur Elena Zaaba; Sumaya Beegam; Ozaz Elzaki; Javed Yasin; Bilal Mohamed Nemmar; Badreldin H Ali; Ernest Adeghate; Abderrahim Nemmar
Journal:  Biomedicines       Date:  2022-04-03

4.  PTR1-dependent synthesis of tetrahydrobiopterin contributes to oxidant susceptibility in the trypanosomatid protozoan parasite Leishmania major.

Authors:  Bakela Nare; Levi A Garraway; Tim J Vickers; Stephen M Beverley
Journal:  Curr Genet       Date:  2009-04-25       Impact factor: 3.886

5.  Pteridine-2,4-diamine derivatives as radical scavengers and inhibitors of lipoxygenase that can possess anti-inflammatory properties.

Authors:  Eleni Pontiki; Dimitra Hadjipavlou-Litina; Alexandros Patsilinakos; Trang M Tran; Charles M Marson
Journal:  Future Med Chem       Date:  2015-10-01       Impact factor: 3.808

Review 6.  Neopterin, Inflammation, and Oxidative Stress: What Could We Be Missing?

Authors:  Steven P Gieseg; Gregory Baxter-Parker; Angus Lindsay
Journal:  Antioxidants (Basel)       Date:  2018-06-26

7.  Relationship Between Serum Neopterin Level and Peripheral Arterial Plaque in Patients with Type 2 Diabetes.

Authors:  Long-Yi Zheng; Jin Lu; Ren-Hui Wan; Yang Yuan; Wei Hao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-28       Impact factor: 3.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.